​Athera raises 55 million SEK in new share issue

Document -

​Athera raises 55 million SEK in new share issue

Biotech company Athera announce the closing of new share issue, raising in total 55 million SEK from current major shareholders including Industrifonden and Östersjöstiftelsen, together with new shareholders from the Sciety network of investors. The new capital will be used for a clinical Phase 2 study and Athera aims for partnering with a larger industry actor when the study is completed.
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Contacts

James Hall

Press contact Chief Executive officer; MD, PhD Chief Executive officer; MD, PhD +46705775300

Carina Schmidt

Press contact Senior Business Advisor, M.Sc. Senior Business Advisor, M.Sc. +46 (0)76-1938190

Related content

​Athera raises 55 million SEK in new share issue

Biotech company Athera announce the closing of new share issue, raising in total 55 million SEK from current major shareholders including Industrifonden and Östersjöstiftelsen, together with new shareholders from the Sciety network of investors. The new capital will be used for a clinical Phase 2 study and Athera aims for partnering with a larger industry actor when the study is completed.